$ELDN
Eledon Pharmaceuticals, Inc.

2019 Q3 Form 10-Q Financial Statement

#000156459019043039 Filed on November 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q4 2018 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.410M $1.840M $1.850M
YoY Change -23.78% 14.29% -24.49%
% of Gross Profit
Research & Development $1.509M $2.740M $1.651M
YoY Change -8.6% 459.18% 219.34%
% of Gross Profit
Depreciation & Amortization $10.00K $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $2.920M $4.580M $3.499M
YoY Change -16.55% 117.06% 18.01%
Operating Profit -$2.920M -$3.499M
YoY Change -16.55% 18.01%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $27.00K $0.00 $3.000K
YoY Change 800.0% -100.0% -160.0%
Pretax Income -$2.890M -$4.570M -$3.500M
YoY Change -17.43% 116.59% 17.85%
Income Tax
% Of Pretax Income
Net Earnings -$2.893M -$4.570M -$3.496M
YoY Change -17.25% 116.59% 17.71%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$4.014M -$8.788M -$6.731M
COMMON SHARES
Basic Shares Outstanding 12.97M 9.422M 9.422M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.80M $13.00M $16.30M
YoY Change -33.74% -24.42% -14.66%
Cash & Equivalents $10.81M $12.97M $16.32M
Short-Term Investments
Other Short-Term Assets $15.00K $36.00K $15.00K
YoY Change 0.0% 100.0% -99.21%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.30M $14.28M $17.11M
YoY Change -28.14% -24.86% -18.52%
LONG-TERM ASSETS
Property, Plant & Equipment $7.000K $14.00K $17.00K
YoY Change -58.82% -44.0%
Goodwill $1.867M $1.867M $1.867M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $688.0K $869.0K $934.0K
YoY Change -26.34% 834.0%
Total Long-Term Assets $2.922M $2.750M $2.818M
YoY Change 3.69% 45.35% 40.9%
TOTAL ASSETS
Total Short-Term Assets $12.30M $14.28M $17.11M
Total Long-Term Assets $2.922M $2.750M $2.818M
Total Assets $15.22M $17.03M $19.93M
YoY Change -23.64% -18.5% -13.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $256.0K $689.0K $751.0K
YoY Change -65.91% 64.83% 275.5%
Accrued Expenses $1.400M $1.800M $900.0K
YoY Change 55.56% 80.0% -57.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.661M $2.534M $1.600M
YoY Change 3.81% 81.0% -30.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $200.0K
YoY Change
Total Long-Term Liabilities $200.0K $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.661M $2.534M $1.600M
Total Long-Term Liabilities $200.0K $0.00 $0.00
Total Liabilities $1.852M $2.534M $1.603M
YoY Change 15.53% 75.97% -33.21%
SHAREHOLDERS EQUITY
Retained Earnings -$53.44M -$41.57M -$37.00M
YoY Change 44.44% 51.13%
Common Stock $66.80M $56.06M $55.32M
YoY Change 20.75% 19.39% 790214.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.37M $14.49M $18.33M
YoY Change
Total Liabilities & Shareholders Equity $15.22M $17.03M $19.93M
YoY Change -23.64% -18.5% -13.36%

Cashflow Statement

Concept 2019 Q3 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$2.893M -$4.570M -$3.496M
YoY Change -17.25% 116.59% 17.71%
Depreciation, Depletion And Amortization $10.00K $0.00 $0.00
YoY Change
Cash From Operating Activities -$2.880M -$3.350M -$2.930M
YoY Change -1.71% 28.35% -14.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 70.00K
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -2.880M -3.350M -2.930M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 0.000 70.00K
Net Change In Cash -2.880M -3.350M -2.860M
YoY Change 0.7% 80.11% -16.37%
FREE CASH FLOW
Cash From Operating Activities -$2.880M -$3.350M -$2.930M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41571000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1411000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
2920000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
689000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
360000
CY2019Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1228000
CY2019Q3 us-gaap Cash
Cash
10814000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1661000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
191000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1482000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
12296000
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2018Q4 us-gaap Cash
Cash
12972000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1304000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14276000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14000
CY2019Q3 us-gaap Goodwill
Goodwill
1867000
CY2018Q4 us-gaap Goodwill
Goodwill
1867000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3499000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
869000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
256000
CY2019Q3 us-gaap Assets
Assets
15218000
CY2018Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1845000
CY2018Q4 us-gaap Assets
Assets
17026000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
688000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2534000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
177000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1065000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8864895
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12974923
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
13000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15218000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1509000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12974923
CY2019Q3 us-gaap Liabilities
Liabilities
1852000
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
66791000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56054000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53438000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
13366000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
14492000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17026000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9422143
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9422143
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1651000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6795000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1848000
CY2018Q4 us-gaap Liabilities
Liabilities
2534000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4077000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5089000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5406000
us-gaap Operating Expenses
OperatingExpenses
9483000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9483000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
18325000
us-gaap Operating Expenses
OperatingExpenses
11884000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2920000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3499000
us-gaap Operating Income Loss
OperatingIncomeLoss
-11884000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-979000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12972000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17303000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10814000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2893000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-3496000
us-gaap Net Income Loss
NetIncomeLoss
-11867000
us-gaap Net Income Loss
NetIncomeLoss
-9491000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.07
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12974923
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9420039
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11397364
nvus Share Issuance At Market Value
ShareIssuanceAtMarketValue
107000
nvus Stock Issued During Period Value Common Stock And Warrants
StockIssuedDuringPeriodValueCommonStockAndWarrants
9569000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
16032000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
227000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
19452000
nvus Share Issuance At Market Value
ShareIssuanceAtMarketValue
7491000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
802000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
21513000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
237000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8000
nvus Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
129000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1065000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
803000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
23000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1050000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
163000
nvus Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-121000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11834000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8540000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9676000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7490000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
71000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9676000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7561000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2158000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16324000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.86%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company&#8217;s financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s unaudited condensed consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s financial statements relate to stock-based compensation, accruals for liabilities, operating lease liability, carrying value of goodwill, and other matters that affect the condensed consolidated financial statements and related disclosures. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the <font style="color:#000000;">condensed </font>consolidated financial statements. </p>
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
194000
CY2019Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
188000
CY2019Q3 nvus Working Capital
WorkingCapital
10600000
CY2019Q3 nvus Closing Bid Price Per Nasdaq Listing Notification Letter
ClosingBidPricePerNASDAQListingNotificationLetter
1.00
CY2019Q3 nvus Consecutive Business Days For Closing Bid Price Of Common Stock
ConsecutiveBusinessDaysForClosingBidPriceOfCommonStock
P30D
CY2019Q3 nvus Stock Market Granted Additional Calendar Days
StockMarketGrantedAdditionalCalendarDays
P180D
CY2019Q3 nvus Closing Bid Price Of Common Stock Per Nasdaq Listing Notification Letter
ClosingBidPriceOfCommonStockPerNASDAQListingNotificationLetter
1.00
CY2019Q3 nvus Number Of Consecutive Business Days Required To Regain Compliance
NumberOfConsecutiveBusinessDaysRequiredToRegainCompliance
P10D
nvus Cash Cash Equivalents And Restricted Cash Maturity Period
CashCashEquivalentsAndRestrictedCashMaturityPeriod
three months or less
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2019Q3 nvus Net Loss Used In The Calculation Of Basic And Diluted Loss Per Share
NetLossUsedInTheCalculationOfBasicAndDilutedLossPerShare
-2893000
CY2018Q3 nvus Net Loss Used In The Calculation Of Basic And Diluted Loss Per Share
NetLossUsedInTheCalculationOfBasicAndDilutedLossPerShare
-3496000
nvus Net Loss Used In The Calculation Of Basic And Diluted Loss Per Share
NetLossUsedInTheCalculationOfBasicAndDilutedLossPerShare
-11867000
nvus Net Loss Used In The Calculation Of Basic And Diluted Loss Per Share
NetLossUsedInTheCalculationOfBasicAndDilutedLossPerShare
-9491000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8770947
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1386588
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2019Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2019Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q3 us-gaap Prepaid Insurance
PrepaidInsurance
308000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
413000
CY2019Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
203000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
261000
CY2019Q3 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
956000
CY2018Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
583000
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
15000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
47000
CY2019Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
415000
CY2018Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
742000
CY2019Q3 nvus Accrued Clinical Current
AccruedClinicalCurrent
387000
CY2018Q4 nvus Accrued Clinical Current
AccruedClinicalCurrent
735000
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
209000
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
160000
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14000
CY2019Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
47000
CY2018Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
42000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
142000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
126000
nvus Lessee Operating Lease Remaining Term Of Contract
LesseeOperatingLeaseRemainingTermOfContract
P2Y
CY2019Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
0
us-gaap Operating Lease Cost
OperatingLeaseCost
147000
us-gaap Operating Lease Payments
OperatingLeasePayments
134000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
489000
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0325
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
47000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
188000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
146000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
381000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
368000
nvus Number Of Milestones Achieved
NumberOfMilestonesAchieved
0
CY2018 nvus Number Of Milestones Achieved
NumberOfMilestonesAchieved
0
CY2019Q1 nvus Milestone Payment Made
MilestonePaymentMade
300000
CY2019Q3 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2019Q3 nvus Contingent Liability
ContingentLiability
0
CY2018 nvus Effective Federal And State Income Tax Rate
EffectiveFederalAndStateIncomeTaxRate
0.21
nvus Effective Federal And State Income Tax Rate
EffectiveFederalAndStateIncomeTaxRate
0.21
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
227000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
237000

Files In Submission

Name View Source Status
0001564590-19-043039-index-headers.html Edgar Link pending
0001564590-19-043039-index.html Edgar Link pending
0001564590-19-043039.txt Edgar Link pending
0001564590-19-043039-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nvus-10q_20190930.htm Edgar Link pending
nvus-20190930.xml Edgar Link completed
nvus-20190930.xsd Edgar Link pending
nvus-20190930_cal.xml Edgar Link unprocessable
nvus-20190930_def.xml Edgar Link unprocessable
nvus-20190930_lab.xml Edgar Link unprocessable
nvus-20190930_pre.xml Edgar Link unprocessable
nvus-ex311_7.htm Edgar Link pending
nvus-ex312_6.htm Edgar Link pending
nvus-ex321_9.htm Edgar Link pending
nvus-ex322_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending